Healthcare expert Spencer Nam joins InFocus Capital PartnersRobert M. Goldman, CFA
InFocus Capital Partners, LLC is well positioned to help high quality private and public companies Be Understood, Be Seen, and Stay in Focus. We believe visibility aids institutional investor and corporate relationships, valuations, liquidity, corporate development, new hire activity, and employee morale. If your company, private or public, would benefit from increased recognition amongst high quality institutional investors and corporations contact us – we can help.
InFocus Capital Partners is pleased to announce that Spencer Nam has joined our team as a Senior Advisor. Robert Goldman, Founder and President of InFocus Capital Partners, says “I have known Spencer and have respected his work for many years. Few have as deep and broad a background in healthcare as does Spencer – in venture capital, consulting, international policy, and equity research. I am honored and humbled that he elected to join our team.”
Mr. Nam has 20 years of experience spanning healthcare investing, disruptive innovations, equity research, and advising senior executives. Most recently, he has been a Managing Director at SV Investments, a healthcare venture capital fund. He has also been a senior research fellow at the Christensen Institute for Disruptive Innovation (founded by Clayton Christensen, Professor at Harvard Business School) where his research has focused on disruptive innovations in the healthcare industry.
Mr. Nam has worked with U.S. and international healthcare enterprises, most recently as an equity research analyst covering more than 50 medical technology and diagnostics companies. He also has advised numerous privately owned medical technology companies as well as the South Korean government on building healthcare ecosystems.
Spencer’s Wall Street career as a senior research analyst included tenures at Cowen & Company, Summer Street Research Partners, Madison Williams and Company, ThinkEquity, and Janney Montgomery Scott. Prior to his career in equity research, he was a consultant at Bain & Company advising senior management teams of Fortune 500 technology and financial services companies. As a member of the investment team at Technology Directors, he researched early-stage venture capital financed technology and life science companies. Prior to Bain, Spencer advised Partners Healthcare System in Boston on post merger integrations.
Spencer holds a BA in mathematics from Harvard University and an MBA from the Harvard Business School.